Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SWT1 RNA endoribonuclease homolog is a nuclear protein encoded by the SWT1 gene, functioning as an endoribonuclease involved in transcription and the quality control of mRNAs, particularly in the processing and surveillance of aberrant messenger ribonucleoprotein particles (mRNPs)[4][7]. It is predicted to localize to the nucleus and is considered essential in regulating proper RNA metabolism. SWT1 has been implicated in certain cancers, including kidney rhabdoid cancer and kidney sarcoma, though no therapeutic drugs are reported to directly target this protein as of the available literature[2][3][6]. The gene is also referred to as C1orf26 and HsSwt1 in genomic databases.
Not established for any approved drugs; theoretical mechanisms may include modulation of RNA processing or transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SWT1 RNA endoribonuclease homolog (SWT1).